Glivec
(Imatinib)
(100 mg)
(120)
(Tablets)
Glivec (imatinib) 100 mg 120 tab. NOVARTIS Switzerland
Article:
Interchangeable drugs with the same active ingredient:
- Alvotinib
- Vinat
- Vinat 100
- Vinat-100-Health
- Glivec
- Imatib
- Imatinib Actavis
- Imatinib Grindeks
- Imatinib Zentiva
- Imatinib Medak
- Imatinib-Teva
- Myelofar
- neopax
Indications
- Treatment of patients (adults and children) with newly diagnosed chronic myeloid leukemia;
- Treatment of patients (adults and children) with chronic myeloid leukemia in the blast crisis phase and the acceleration phase and in the chronic phase after unsuccessful therapy with interferon alfa;
- Treatment of adult patients with newly diagnosed positive (with the presence in the leukocytes of the Philadelphia chromosome (bcr-abl) acute lymphoblastic leukemia as part of chemotherapy;
- Treatment of adult patients with acute lymphoblastic leukemia in the stage of relapse or with persistent tolerance to chemotherapy as monotherapy;
- Treatment of adult patients with myelodysplastic / myeloproliferative diseases associated with platelet growth factor receptor activation;
- Treatment of adult patients with systemic mastocytosis with no D816B c-Kit mutations or no evidence of c-Kit mutational status;
- Treatment of adults with hypereosinophilic syndrome and/or chronic ezosinophilic leukemia;
- Treatment of adult patients with Kit (CD117) positive inoperable and / or metastatic malignant tumors of the stroma of the digestive tract;
- 637566862;6;632532028;7.3
- Treatment of patients with unresectable and/or metastatic dermatofibrosarcoma.
- 320ct
-
Commercial name:Glivec
-
Сhemical name:Imatinib
-
Dosage:100 mg
-
Quantity:120
-
Release form:Tablets
No reviews yet